Skip to content
GenoLensGenoLens

HGSNAT

Chr 8p11.21-p11.1

heparan-alpha-glucosaminide N-acetyltransferase

Aliases:
FLJ32731, HGNAT
MANE:
ENST00000379644.9

Annotations refreshed 1 month ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • DDG2P

    BIALLELIC, autosomal or pseudoautosomal
  • Intellectual disability

    BIALLELIC, autosomal or pseudoautosomal
  • Likely inborn error of metabolism

    BIALLELIC, autosomal or pseudoautosomal
  • Lysosomal storage disorder

    BIALLELIC, autosomal or pseudoautosomal
  • Mucopolysaccharideosis, Gaucher, Fabry

    BIALLELIC, autosomal or pseudoautosomal
  • Retinal disorders

    BIALLELIC, autosomal or pseudoautosomal
  • Skeletal dysplasia

    BIALLELIC, autosomal or pseudoautosomal
  • Undiagnosed metabolic disorders

    BIALLELIC, autosomal or pseudoautosomal

+4 more panels — install the extension to see the full list inline on any page.

Disease associations (Open Targets)

  • mucopolysaccharidosis type 3C

    0.85
  • retinitis pigmentosa 73

    0.78
  • mucopolysaccharidosis type 3

    0.75
  • retinitis pigmentosa

    0.68
  • Retinal dystrophy

    0.55
  • neurodegenerative disease

    0.47
  • hereditary disease

    0.47
  • inherited retinal dystrophy

    0.37
  • synovial plica syndrome

    0.27
  • retinal disorder

    0.12

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Heparan-alpha-glucosaminide N-acetyltransferase

Lysosomal acetyltransferase that acetylates the non-reducing terminal alpha-glucosamine residue of intralysosomal heparin or heparan sulfate, converting it into a substrate for luminal alpha-N-acetyl glucosaminidase

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.